{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T15:06:24Z","timestamp":1777820784895,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jcjo.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:47:03Z","timestamp":1685188023000},"page":"e309-e320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Review of clinical trials addressing the Boston Keratoprosthesis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0693-3421","authenticated-orcid":false,"given":"Daniel","family":"Milad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerolos","family":"Eisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Harissi-Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2023.05.003_bib0001","article-title":"Artificial corneas versus donor corneas for repeat corneal transplants","volume":"5","author":"Chen","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/0301-4738.100540","article-title":"Turning the tide of corneal blindness","volume":"60","author":"Oliva","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0003","series-title":"Keratoprostheses and artificial corneas","first-page":"51","article-title":"Indications and contraindications of Boston KPro types I and II","author":"Robert","year":"2015"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0004","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2015.03.025","article-title":"Boston Keratoprosthesis: outcomes and complications. A report by the American Academy of Ophthalmology","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0005","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/OPTH.S219270","article-title":"Boston Type 1 Keratoprosthesis: updated perspectives","volume":"14","author":"Nonpassopon","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0006","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ophtha.2006.05.015","article-title":"Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston type 1 keratoprosthesis study","volume":"113","author":"Zerbe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jcjo.2017.10.021","article-title":"Boston Type 1 Keratoprosthesis Study Group. Outcomes of Boston keratoprosthesis type 1 reimplantation: multicentre study results","volume":"53","author":"Wang","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0008","series-title":"Evidence-based medicine (EBM)","author":"Tenny","year":"2018"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0009","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.284.10.1290","article-title":"Users\u2019 guides to the medical literature: XXV. Evidence-based medicine: principles for applying the users\u2019 guides to patient care. Evidence-Based Medicine Working Group","volume":"284","author":"Guyatt","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0011","unstructured":"Agency for Healthcare Research and Quality. Guidelines and measures: Information about the National Clearinghouse [Internet]. N.d. Available at: http:\/\/www.guidelines.gov\/summary\/summary.asp (accessed November 22, 2020)."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0012","unstructured":"National Institutes of Health. NIH's definition of a clinical trial [Internet]. N.d. Available at: https:\/\/grants.nih.gov\/policy\/clinical-trials\/definition.htm (accessed May 17, 2022)."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0013","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ICL.0000000000000081","article-title":"Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients","volume":"40","author":"Robert","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0014","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/jop.2015.0010","article-title":"Evaluation of the effect of N-acetylcysteine on protein deposition on contact lenses in patients with the Boston Keratoprosthesis type I","volume":"31","author":"Kruh","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICO.0b013e31823e6110","article-title":"Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers","volume":"31","author":"Robert","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ophtha.2016.07.019","article-title":"Boston keratoprosthesis type 1: a randomized controlled trial of fresh versus frozen corneal donor carriers with long-term follow-up","volume":"124","author":"Muzychuk","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcjo.2021.02.033","article-title":"Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes","volume":"57","author":"Sabeti","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0018","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3129\/i06-060","article-title":"Demographics of corneal transplantation in Canada in 2004","volume":"41","author":"Cao","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0019","first-page":"385","article-title":"Growing waiting list for corneal transplantation [Swedish]","volume":"99","author":"Fagerholm","year":"2002","journal-title":"Lakartidningen"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2018.09.028","article-title":"Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery","volume":"126","author":"Enders","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0021","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2019.02.025","article-title":"Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery using the EYEMATE-IO sensor: dynamics in the first year","volume":"206","author":"Enders","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0022","doi-asserted-by":"crossref","unstructured":"Enders P, Cursiefen C. Device profile of the EYEMATE-IO system for intraocular pressure monitoring: overview of its safety and efficacy. Expert Rev Med Devices 2020;17:491\u20137.","DOI":"10.1080\/17434440.2020.1761788"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0023","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0024","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 May 12. Identifier NCT02084745: Timing of glaucoma drainage device with Boston keratoprosthesis [2014 Mar 12]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02084745. Accessed May 21 2022."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0025","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 May 12. Identifier NCT04337944: Endoscopic assisted anterior hyaloid peeling in Boston type 1 keratoprosthesis [2020 Apr 8]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04337944. Accessed May 21 2022."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0026","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 May 12. Identifier NCT04339907: Inflammatory mediators of glaucoma after corneal transplantation [2020 Apr 9]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04339907. Accessed May 21 2022."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0027","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 May 12. Identifier NCT04232982: The role of transscleral cyclophotocagulation in patients undergoing a Boston keratoprosthesis [2020 Jan 18]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04232982. Accessed May 21 2022."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0028","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2017 Feb 3. Identifier NCT03041883: Corneal collagen cross-linking to increase the resistance of the support graft of the KPro type I against corneal melting (CXL-Kpro) [2017 Feb 3]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03041883. Accessed May 21 2022."},{"key":"10.1016\/j.jcjo.2023.05.003_bib0029","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2020 May 12. Identifier NCT02863809: Vision restoration with a collagen cross-linked Boston Keratoprosthesis unit [2016 Aug 11]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02863809. Accessed May 21 2022."},{"issue":"11","key":"10.1016\/j.jcjo.2023.05.003_bib0030","article-title":"Artificial corneas versus donor corneas for repeat corneal transplants","author":"Akpek","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0031","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ophtha.2015.09.028","article-title":"Boston type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure: a systematic review and meta-analysis","volume":"123","author":"Ahmad","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0032","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jtos.2018.03.007","article-title":"Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: a systematic review","volume":"16","author":"Shanbhag","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0033","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0000000000002098","article-title":"Systematic review and meta-analysis of the medium-and long-term outcomes of the Boston type 1 keratoprosthesis","volume":"38","author":"Priddy","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.sjopt.2015.02.001","article-title":"Boston keratoprosthesis\u2014clinical outcomes with wider geographic use and expanding indications: a systematic review","volume":"29","author":"Al Arfaj","year":"2015","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ophtha.2011.11.030","article-title":"Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Boston Type 1 Keratoprosthesis Study Group","volume":"119","author":"Rudnisky","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2023.05.003_bib0036","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ophtha.2012.11.025","article-title":"Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results","volume":"120","author":"Ciolino","year":"2013","journal-title":"Ophthalmology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T18:53:47Z","timestamp":1721156027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418223001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0008418223001667"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.05.003","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of clinical trials addressing the Boston Keratoprosthesis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}